CLINICAL_TRIALS
trial_result
· 2026-06-29
Clinical Trial Results: Tofacitinib in Recurrent GBM Patients [Phase 3]
Summary
Phase 3 trial results for tofacitinib in recurrent glioblastoma completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Glioblastoma | Phase 3 | Status: COMPLETED | Results posted: 2026-06-29